当前位置: 首页 > 期刊 > 《中国医药科学》 > 2014年第9期
编号:13129816
SIRT1在非小细胞肺癌中的表达及相关性研究(3)
http://www.100md.com 2014年5月1日 逄旭梅△  于国华▲  张居民
第1页

    参见附件。

     [10] 孙雪林,卜培莉.组蛋白去乙酰化酶SIRT1在不同类型房颤患者中的作用机制研究[D].山东:山东大学,2012:3-15.

    [11] Liu T,Liu PY,Marshall GM.The critical role of the class III histone deacetylase SIRT1 in cancer[J].Cancer Res,2011,69:1702-1705.

    [12] 曹琼,金戈.TRAIL对耐药相关基因SIRT1作用效应的研究[D].郑州:郑州大学,2011:4-16.

    [13] Huffman DM,Grizzle WE,Bamman MM,et al.SIRT1 is significantly elevated in mouse and human prostate cancer[J].Cancer Res,2011,67:6612-6618.

    [14] Bradbury CA,Khanim FL,Hayden R,et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors[J].Leukemia,2010,19:1751-1759.

    [15] 朱小霞,邹和建.Sirt1对硬皮病模型小鼠的干预作用及其机制研究[D].上海:复旦大学,2012:4-15.

    [16] Lim CS.SIRT1:tumor promoter or tumor suppressor?[J].Med Hcpotheses,2012,67:341-344 .

    [17] Powell MJ,Casimiro MC,Cordon-Cardo C,et al.Disruption of a Sirtl-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation[J].Cancer Res,2011,71(3):964-975.

    [18] Wang RH,Zheng Y,Kim HS,et al.Interplay among BRCA1,SlRT1,and Survivin during BRCA1-associated tumorigenesis[J].Mol Cell,2011,32(1):11-20.

    (收稿日期:2014-02-13)

您现在查看是摘要介绍页,详见PDF附件